Senior Manager, Payer Value & Outcomes
Jazz Pharmaceuticals
Summary
The Senior Manager, Payer, Value & Outcomes (PVO) serves an internal support role by providing PVO focused training, communications and resource development across the Jazz portfolio and pipeline. As Payers and other Population Health Decision Makers (PHDMs) continue to shift to more restrictive utilization management strategies, special evidentiary requirements including real-world evidence (RWE) and health care economic information (HCEI) become increasingly important to clinically differentiate/highlight the value of Jazz's products. The Senior Manager, PVO supports evidence dissemination through resource development/updates which incorporates data relevant to PHDMs to inform managed care decision making for Jazz products. The Senior Manager, PVO works primarily with the PVO product leads but also collaborates with other Medical Affairs colleagues and cross-functional partners (Global Health Economics & Outcomes Research (GHEOR), Real World Evidence (RWE), MedComms, Market Access, etc.). This position is remote and candidate can be located anywhere in the US.
Job description
Essential Functions
Clinical and Value Medical Field Resource Development and Maintenance
- Develop and Update PVO Resources across all Jazz therapeutic areas including pipeline + monitor expiration/updates as needed.
- Serve as MARC Medical Material Owner (MMO) for all products to shepherd customer facing resources through the resource approval process.
- Collaborate as needed with resource vendors and internalize a portion of this work as appropriate + provide key resource status updates to PVO colleagues.
- Coordinate with MedComms, GVHEOR and RWE Teams + align with Market Access resources as appropriate.
Medical Value Training
- Coordinate and Execute Scientific PVO Specific Training, conduct needs assessments and competency evaluations.
- Develop/Update/Coordinate PVO Onboarding and PVO Litmos Training Plans
- Collaborate with training vendors and internalize a portion of this work as appropriate.
- Coordinate/Align with L&D Team, PVO product leads and other internal partners (Market Access, GHEOR, RWE, etc.)
Communications/Coordination
- Assist PVO product leads with Packaging/Analysis of customer insights/policy/access trends to inform development of impactful value evidence generation and clinical development plans for marketed and pipeline products.
- Ensure Compliance with all applicable laws, regulations and regulatory guidelines governing commercial and scientific interactions with healthcare professionals, payers, advocacy and other business partners.
Requirements
- Advanced Degree Required (PharmD, PhD, MD, NP or PA)
- Minimum of 5 years of post-doctoral relevant scientific work experience in pharmaceutical industry medical writing, MedComms, medical value and access and/or related disciplines
- Demonstrated proficiency in managing and maintaining knowledge in multiple therapeutic areas (neuroscience, hematology/oncology and rare disease strongly preferred)
- In-depth knowledge of the biopharmaceutical industry and US managed markets, including various access and reimbursement models
- Demonstrated familiarity with managed care, population health, health outcomes, health policy, health technology assessment, and pharmacoeconomic principles including AMCP Dossiers, 21st Century Cures Act, PIE Act, ICER and application of HCEI
- Excellent analytical, written, and verbal communication
- Medical writing, Medical Affairs resource development, resource approval process experience required
- Strong personal integrity, interpersonal skills, teamwork abilities and customer focus
- Demonstrated ability to organize, adapt, prioritize, and work effectively in a matrixed organization and in an evolving/changing health care environment
- Ability to travel approximately 20-30% of time
Benefits
- Medical, Dental & Vision
- 401(k) Matching
- Flexible Paid Vacation
- Discretionary Annual Cash Bonus
- Incentive Compensation
- Discretionary Equity Grants
Company overview
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharmaceutical company headquartered in Dublin, Ireland, with significant operations in the United States and Europe. Founded in 2003 in California, the company specializes in developing and commercializing innovative medicines for patients with serious diseases, with a primary focus on oncology and neuroscience. Jazz Pharmaceuticals is renowned for its flagship product Xyrem (sodium oxybate), which treats excessive daytime sleepiness and cataplexy in narcolepsy patients, generating substantial revenue for the company. The company's portfolio also includes treatments for epilepsy, sleep disorders, hematology, and oncology, with notable products such as Erwinaze, Defitelio, FazaClo, and Vyxeos. Through strategic acquisitions including GW Pharmaceuticals in 2021, Jazz expanded its neuroscience portfolio with cannabis-based medicines like Epidiolex for severe epilepsy syndromes. With approximately 2,800 employees worldwide and operations across multiple continents, Jazz Pharmaceuticals maintains a strong commitment to research and development, focusing on transforming biopharmaceutical discoveries into novel therapies for patients with limited treatment options. The company operates manufacturing facilities in Ireland, England, and Italy, and continues to pursue innovative approaches to address critical unmet medical needs in specialized therapeutic areas.